Cybin Corp - CYBN Net Assets per Single Share

Graphic logo of Cybin (CYBN)

The price indicator on the Cybin Inc. (CYBN) chart reflects the price action of an asset whose operations are constrained by strict DEA oversight and complex patent protection for new compounds. The current reading is 5.34, while business success depends on the results of final antidepressant trials supported by sufficient capital reserves. Cybin Inc. (CYBN) acts as a biopharmaceutical pioneer, implementing smart delivery systems for modified molecules to treat psychiatric disorders.

Cybin Corp (CYBN): Share Book Value from 07/04/2022 to 01/05/2026

Cybin Inc - analytical breakdowns and key metrics (CYBN)

- price and consensus price forecast:
Stock Price Cybin Corp|CYBN - Price Target Chart
- market capitalization data:
Market Value Cybin Inc.|CYBN - Business Value
- book capitalization data:
Net Assets per Single Share Cybin|CYBN - Net Asset Value|Market Capitalization to Book Value Ratio cybin.com|CYBN - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Cybin Inc.|CYBN - Long-Term Debt to Capital|Short-Term Debt to Equity Cybin Corp|CYBN - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Cybin Inc.
Fundamental company valuation:cybin.com - CYBN
Manufactured products of Cybin Corp

Book value per share determines the net asset value attributable to a single security after deducting all liabilities, serving as an indicator of intrinsic capital stability. By analyzing the book value per share of Cybin Inc. (CYBN), an investor assesses the financing efficiency of psilocybin drug development, where maintaining the asset base is critical for the long-term penetration of the psychiatry market.

Competitors of Cybin Inc. (CYBN)

ALKS - Book Value per Share|AVDL: Net Assets per Single Share|Net Assets per Single Share Atai Life Sciences N.V.|GHRS (ghres.com) - Equity per Share|Net Assets per Single Share MindMed MNMD|Share Book Value COMPASS Pathways PLC|LB Pharma (LBRX) - Book Value per Share|Accounting Value of a Share Bright Minds Corp (DRUG)|Book Value per Share VNDA (Vanda Pharmaceuticals)|altoneuroscience.com - Book Value per Share|Net Assets per Single Share NRx Pharmaceuticals, Inc. (NRXP)|CING: Accounting Value of a Share|SILO (Silo Pharma, Inc.) - Net Assets per Single Share|China Pharma Holdings, Inc. (CPHI) - Accounting Value per Share|CMND (Clearmind Medicine) - Book Value per Share|Book Value per Share pacificbayminerals.com (PBM)|SciSparc (SPRC) - Accounting Value per Share|Accounting Value of a Share SEEL (Seelos Therapeutics Inc.)|Virpax Pharmaceuticals, Inc. (VRPX) - Net Assets per Single Share|Karuna Pharma - Share Book Value